(MS) Morgan Stanley - Overview
Stock: Advisory, Brokerage, Lending, Asset Management, Investment Banking
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.66% |
| Yield on Cost 5y | 6.20% |
| Yield CAGR 5y | 16.36% |
| Payout Consistency | 90.1% |
| Payout Ratio | 31.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.0% |
| Relative Tail Risk | -7.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.90 |
| Alpha | 13.77 |
| Character TTM | |
|---|---|
| Beta | 1.311 |
| Beta Downside | 1.438 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.24% |
| CAGR/Max DD | 0.91 |
Description: MS Morgan Stanley January 26, 2026
Morgan Stanley (NYSE: MS) is a diversified financial holding company operating through three core segments-Institutional Securities, Wealth Management, and Investment Management. It delivers capital-raising, underwriting, and advisory services for debt, equity and M&A transactions; provides equity and fixed-income sales, financing, prime brokerage, and market-making; and offers a broad suite of wealth-planning, brokerage, lending, custody, and retirement-plan solutions to governments, institutions, and individual clients worldwide.
In its most recent quarter (Q3 2024), Morgan Stanley reported net revenue of **$13.2 billion**, a **4 % year-over-year increase** driven primarily by a rebound in Institutional Securities underwriting and a **7 % rise** in Wealth Management assets under management to **$2.2 trillion**. Net income rose to **$3.5 billion** (up 12 % YoY), and the firm’s operating margin held at **≈20 %**. Key sector drivers include: (1) a **high-interest-rate environment** that lifts net interest income on securities financing; (2) **elevated global M&A activity**, with deal value up ~15 % YoY, supporting advisory fees; and (3) **robust growth in Asian wealth management**, where AUM expanded 9 % driven by rising high-net-worth populations. The bank’s return on equity remains around **13 %**, consistent with the broader investment-banking peer group.
For a deeper, data-rich perspective on how these trends translate into valuation signals, consider exploring the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 16.86b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 2.11 > 1.0 |
| NWC/Revenue: -537.4% < 20% (prev -244.1%; Δ -293.3% < -1%) |
| CFO/TA -0.00 > 3% & CFO -3.68b > Net Income 16.86b |
| Net Debt (414.62b) to EBITDA (26.56b): 15.61 < 3 |
| Current Ratio: 0.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.59b) vs 12m ago -0.93% < -2% |
| Gross Margin: 57.48% > 18% (prev 0.56%; Δ 5693 % > 0.5%) |
| Asset Turnover: 9.00% > 50% (prev 8.49%; Δ 0.51% > 0%) |
| Interest Coverage Ratio: 0.45 > 6 (EBITDA TTM 26.56b / Interest Expense TTM 49.02b) |
Altman Z'' -2.62
| A: -0.46 (Total Current Assets 216.31b - Total Current Liabilities 840.30b) / Total Assets 1364.81b |
| B: 0.08 (Retained Earnings 112.43b / Total Assets 1364.81b) |
| C: 0.02 (EBIT TTM 21.95b / Avg Total Assets 1289.94b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 1253.76b) |
| Altman-Z'' Score: -2.62 = D |
What is the price of MS shares?
Over the past week, the price has changed by -1.55%, over one month by -3.62%, over three months by +10.73% and over the past year by +30.98%.
Is MS a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 17
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 195.4 | 8.6% |
| Analysts Target Price | 195.4 | 8.6% |
| ValueRay Target Price | 217.7 | 21% |
MS Fundamental Data Overview January 31, 2026
P/E Forward = 16.0514
P/S = 4.1329
P/B = 2.5186
P/EG = 1.6712
Revenue TTM = 116.11b USD
EBIT TTM = 21.95b USD
EBITDA TTM = 26.56b USD
Long Term Debt = 332.20b USD (from longTermDebt, two quarters ago)
Short Term Debt = 82.43b USD (from shortTermDebt, two quarters ago)
Debt = 414.62b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 414.62b USD (using Total Debt 414.62b, CCE unavailable)
Enterprise Value = 705.15b USD (290.53b + Debt 414.62b - (null CCE))
Interest Coverage Ratio = 0.45 (Ebit TTM 21.95b / Interest Expense TTM 49.02b)
EV/FCF = -104.5x (Enterprise Value 705.15b / FCF TTM -6.75b)
FCF Yield = -0.96% (FCF TTM -6.75b / Enterprise Value 705.15b)
FCF Margin = -5.81% (FCF TTM -6.75b / Revenue TTM 116.11b)
Net Margin = 14.52% (Net Income TTM 16.86b / Revenue TTM 116.11b)
Gross Margin = 57.48% ((Revenue TTM 116.11b - Cost of Revenue TTM 49.37b) / Revenue TTM)
Gross Margin QoQ = 59.60% (prev 56.85%)
Tobins Q-Ratio = 0.52 (Enterprise Value 705.15b / Total Assets 1364.81b)
Interest Expense / Debt = 2.92% (Interest Expense 12.10b / Debt 414.62b)
Taxrate = 23.19% (1.34b / 5.76b)
NOPAT = 16.86b (EBIT 21.95b * (1 - 23.19%))
Current Ratio = 0.26 (Total Current Assets 216.31b / Total Current Liabilities 840.30b)
Debt / Equity = 3.77 (Debt 414.62b / totalStockholderEquity, two quarters ago 109.96b)
Debt / EBITDA = 15.61 (Net Debt 414.62b / EBITDA 26.56b)
Debt / FCF = -61.45 (negative FCF - burning cash) (Net Debt 414.62b / FCF TTM -6.75b)
Total Stockholder Equity = 107.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.31% (Net Income 16.86b / Total Assets 1364.81b)
RoE = 15.70% (Net Income TTM 16.86b / Total Stockholder Equity 107.37b)
RoCE = 4.99% (EBIT 21.95b / Capital Employed (Equity 107.37b + L.T.Debt 332.20b))
RoIC = 3.81% (NOPAT 16.86b / Invested Capital 442.94b)
WACC = 5.75% (E(290.53b)/V(705.15b) * Re(10.75%) + D(414.62b)/V(705.15b) * Rd(2.92%) * (1-Tc(0.23)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.05%
Fair Price DCF = unknown (Cash Flow -6.75b)
EPS Correlation: 67.67 | EPS CAGR: 7.83% | SUE: 1.19 | # QB: 8
Revenue Correlation: 93.93 | Revenue CAGR: 21.71% | SUE: 3.64 | # QB: 3
EPS next Quarter (2026-03-31): EPS=2.93 | Chg30d=+0.089 | Revisions Net=+10 | Analysts=17
EPS current Year (2026-12-31): EPS=11.32 | Chg30d=+0.734 | Revisions Net=+21 | Growth EPS=+10.9% | Growth Revenue=+8.1%
EPS next Year (2027-12-31): EPS=12.25 | Chg30d=+0.477 | Revisions Net=+12 | Growth EPS=+8.2% | Growth Revenue=+5.1%